Circulation: Cardiovascular quality and outcomes: Scholarship to improve health and health care for patients and populations

Circulation: Cardiovascular Quality and Outcomes

Volumn 1, Issue 1, 2008, Pages 1-3

  Krumholz, Harlan M ^a,b,c  

^a Robert Wood Johnson Clinical Scholars Program   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c YALE NEW HAVEN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; ECONOMICS; EDITORIAL; HEALTH CARE QUALITY; HUMAN; MEDICAL EDUCATION; MEDICAL SOCIETY; OUTCOME ASSESSMENT; PREVENTIVE MEDICINE; PUBLICATION; RESEARCH; UNITED STATES;

AMERICAN HEART ASSOCIATION; CARDIOVASCULAR DISEASES; FELLOWSHIPS AND SCHOLARSHIPS; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PERIODICALS AS TOPIC; PREVENTIVE MEDICINE; QUALITY ASSURANCE, HEALTH CARE; RESEARCH; UNITED STATES;

EID: 77649165764     PISSN: 19417713     EISSN: 19417705     Source Type: Journal    
DOI: 10.1161/CIRCOUTCOMES.108.814509     Document Type: Review

References (12)

1. Krumholz HM. Outcomes research: generating evidence for best practice and policies. Circulation. 2008;118:309 -318.
2. Weintraub WS, Boden WE, Zhang Z, Kolm P, Zhang Z, Spertus JA, Hartigan P, Veledar E, Jurkovitz C, Bowen J, Maron DJ, O'Rourke R, Dada M, Teo KK, Goeree R, Barnett P. Cost-effectiveness of percutaneous coronary intervention in optimally treated stable coronary patients. Circ Cardiovasc Qual Outcomes. 2008;1:12-20.
3. Arnold SV, Decker CJ, Ahmad H, Olabiyi O, Mundluru S, Reid KJ, Soto GE, Gansert S, Spertus JA. Converting the informed consent from a perfunctory process to an evidence-based foundation for patient decision making. Circ Cardiovasc Qual Outcomes. 2008;1:21-28.
4. Keenan PS, Normand S-LT, Lin Z, Drye EE, Bhat KR, Ross JS, Schuur JD, Stauffer BD, Bernheim SM, Epstein AJ, Wang YF, Herrin J, Chen J, Federer JJ, Mattera JA, Wang Y, Krumholz HM. An administrative claims measure suitable for profiling hospital performance on the basis of 30-day all-cause readmission rates among patients with heart failure. Circ Cardiovasc Qual Outcomes. 2008;1:29 -37.
5. Mahoney EM, Wang K, Cohen DJ, Hirsch AT, Alberts MJ, Eagle K, Mosse F, Jackson J, Steg G, Bhatt DL. One-year costs in patients with a history of or at risk for atherothrombosis in the United States. Circ Cardiovasc Qual Outcomes. 2008;1:38-45.
6. Angell SY, Garg RK, Gwynn RC, Bash LD, Thorpe LE, Frieden TR. Prevalence, awareness, treatment, and predictors of control of hypertension in New York City. Circ Cardiovasc Qual Outcomes. 2008;1:46-53.
7. Bonow RO. Measuring quality in heart failure: do we have the metrics? Circ Cardiovasc Qual Outcomes. 2008;1:9 -11.
8. Kirtane AJ, Cohen DJ. When is better not good enough? Insights from the COURAGE economic study. Circ Cardiovasc Qual Outcomes. 2008; 1:4-6.
9. Rao SV, Kim SYH. Informing the consent process. Circ Cardiovasc Qual Outcomes. 2008;1:7-8.
10. Austin PC. Report card on propensity-score matching in the cardiology literature from 2004 to 2006: a systematic review. Circ Cardiovasc Qual Outcomes. 2008;1:62-67.
11. Auerbach A. Changing the practice of perioperative cardioprotection: perioperative -blockers after POISE (PeriOperative ISchemic Evaluation). Circ Cardiovasc Qual Outcomes. 2008;1:58-61.
12. Taylor AJ, Nissen SE. Preliminary observations from preliminary trial results: have we finally had enough? Circ Cardiovasc Qual Outcomes. 2008;1:54 -57.